| Title |
Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues
|
|---|---|
| Published in |
BMC Infectious Diseases, August 2015
|
| DOI | 10.1186/s12879-015-1055-0 |
| Pubmed ID | |
| Authors |
Patricia Kissinger |
| Abstract |
Trichomonas vaginalis (TV) is likely the most common non-viral sexually transmitted infection (STI) in the world. It is as an important source of reproductive morbidity, a facilitator of HIV transmission and acquisition, and thus it is an important public health problem. Despite its importance in human reproductive health and HIV transmission, it is not a reportable disease and surveillance is not generally done. This is problematic since most persons infected with TV are asymptomatic. Metronidazole (MTZ) has been the treatment of choice for women for decades, and single dose has been considered the first line of therapy. However, high rates of retest positive are found among TV infected persons after single dose MTZ treatment. This has not been explained by drug resistance since in vitro resistance is only 2-5 %. Treatment failure can range from 7-10 % and even higher among HIV+ women. Treatment efficacy may be influenced by vaginal ecology. The origins of repeat positives need further explanation and better treatment options are needed. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ecuador | 1 | 10% |
| Brazil | 1 | 10% |
| United States | 1 | 10% |
| Unknown | 7 | 70% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 90% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 603 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Unknown | 602 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 123 | 20% |
| Student > Master | 72 | 12% |
| Student > Ph. D. Student | 47 | 8% |
| Researcher | 34 | 6% |
| Other | 29 | 5% |
| Other | 81 | 13% |
| Unknown | 217 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 111 | 18% |
| Biochemistry, Genetics and Molecular Biology | 75 | 12% |
| Immunology and Microbiology | 49 | 8% |
| Agricultural and Biological Sciences | 49 | 8% |
| Nursing and Health Professions | 22 | 4% |
| Other | 64 | 11% |
| Unknown | 233 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 68. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2023.
All research outputs
#636,360
of 25,603,577 outputs
Outputs from BMC Infectious Diseases
#155
of 8,661 outputs
Outputs of similar age
#7,445
of 276,052 outputs
Outputs of similar age from BMC Infectious Diseases
#3
of 143 outputs
Altmetric has tracked 25,603,577 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,661 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,052 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 143 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.